Technology | Oncology Diagnostics | May 05, 2016

Carestream Releases New PET/CT Oncology Workflow

Company’s enterprise image management system now offers advanced toolset to help improve reading and reporting for tumor detection and tracking

Carestream, oncology workflow, PET/CT, Vue Motion

May 5, 2016 — Carestream now offers an oncology reading workflow for positron emission tomography (PET)/computed tomography (CT) studies. The workflow equips clinicians with new native tools for Carestream’s enterprise image management system that deliver both quantitative and qualitative information to help improve and expedite the reading process in tumor detection and tracking.

Carestream’s new CT Perfusion and Subtraction modules contain interactive tools to ease the process of analyzing and comparing three-dimensional (3D), CT perfusion (CTP) and digital subtraction angiography (DSA) images. This equips users to analyze CT brain perfusion scans for tissue perfusion and tissue blood volume, while X-ray angiography (XA) subtraction capabilities provide a DSA workflow for analysis of vessel blockages in areas with bony or dense soft tissue.

“Carestream’s new CT perfusion module that is native to the PACS [picture archiving and communication system] demonstrated better coherence and consistency of perfusion maps and results and was easy to use,” said Daniel Reizine, M.D., radiologist, Department of Neuroradiology, Hospital Lariboisière, Paris, France.

Carestream also developed PET segmentation that allows users to examine tumor standardized uptake values (SUV) traces on the PET image without the need for a physical trace on a CT exam. This capability can play an important role in detection of early stage cancers.

The company’s streamlined oncology reading workflow includes:

  • Automatic fusion of PET, single photon emission computed tomography (SPECT), CT and magnetic resonance (MR) images;
  • Automatic registration between volumetric datasets that provide efficient comparison of multiple time points;
  • Synchronized manipulations, color maps, measurement tools and pre-defined layouts that aid in analysis;
  • Reproducible 2-D and volumetric lesion segmentation and automated comparison to observe progression over time;
  • Threshold segmentation, spheroid region of interest (ROI), metabolic tumor volume (MTV) and total lesion glycolysis (TLG);
  • Bookmarks to catalog lesions and speed future access; and
  • Precise follow-up data for enhanced patient care.

An efficient reading workflow is supported by use of Carestream’s native Vue Reporting module. Vue Reporting can present interactive hyperlinks to critical images and automatic inclusion of quantitative analysis in the form of easy-to-understand comparison tables and charts.

Vue Reporting also offers bookmarks and lesion management reporting in accordance with international standards such as response evaluation criteria in solid tumors (RECIST). Reports and images can be shared using Carestream’s Vue Motion universal viewer that supports viewing on U.S. Food and Drug Administration (FDA)-approved mobile devices.

For more information: www.carestream.com

Related Content

Paragon Biosciences Launches Qlarity Imaging to Advance FDA-cleared AI Breast Cancer Diagnosis System

Qlarity Imaging’s software is used to assist radiologists in the assessment and characterization of breast lesions. Imaging features are synthesized by an artificial intelligence algorithm into a single value, the QI score, which is analyzed relative to a database of reference abnormalities with known ground truth. Image courtesy of Business Wire.

Technology | Artificial Intelligence | July 18, 2019
Paragon Biosciences LLC announced the launch of its seventh portfolio company, Qlarity Imaging LLC, which was founded...
New Lung Ambition Alliance Aims to Double Five-year Lung Cancer Survival by 2025
News | Lung Cancer | July 17, 2019
The International Association for the Study of Lung Cancer (IASLC), Guardant Health, the Global Lung Cancer Coalition (...
NorthStar Medical Radioisotopes Completes Construction on Beloit, Wis. Molybdenum-99 Processing Facility
News | Radiopharmaceuticals and Tracers | July 16, 2019
NorthStar Medical Radioisotopes LLC  announced completion of construction on its 20,000-square-foot molybdenum-99 (Mo-...
FDA Clears Koios DS Breast 2.0 AI-based Software
News | Ultrasound Women's Health | July 11, 2019
Koios Medical announced its second 510(k) clearance from the U.S. Food and Drug Administration (FDA).
SimonMed Imaging Implements ProFound AI for 3-D Tomosynthesis
News | Mammography | July 10, 2019
Arizona-based SimonMed Imaging announced their implementation of the first U.S. Food and Drug Administration (FDA)-...
Videos | Enterprise Imaging | July 09, 2019
ITN Associate Editor Jeff Zagoudis speaks with Don Dennison
Videos | Enterprise Imaging | July 08, 2019
ITN Associate Editor Jeff Zagoudis speaks with Don Dennison
Hyland Healthcare Adds ImageNext Imaging Workflow Optimizer to Enterprise Imaging Suite
Technology | Enterprise Imaging | July 05, 2019
Hyland Healthcare is launching ImageNext, a vendor-neutral imaging workflow optimizer that combines intelligent imaging...
Therapixel Appoints Matthieu Leclerc-Chalvet as CEO
News | Artificial Intelligence | July 03, 2019
Artificial intelligence (AI) breast cancer screening specialist Therapixel announced the appointment of Matthieu...
Laurel Bridge and 3M M*Modal Partner to Improve DICOM Structured Reporting
News | PACS | July 02, 2019
July 2, 2019 — Laurel Bridge Software announced an expanded relationship with 3M M*Modal, a provider of clinical docu